Page last updated: 2024-09-03

gefitinib and deferoxamine

gefitinib has been researched along with deferoxamine in 3 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(deferoxamine)
Trials
(deferoxamine)
Recent Studies (post-2010) (deferoxamine)
5,2315662,9196,7032401,266

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)deferoxamine (IC50)
Lysine-specific demethylase 4AHomo sapiens (human)3.275
Deoxyhypusine hydroxylaseHomo sapiens (human)5

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Aragon-Sanabria, V; Bradbury, MS; Brennan, C; Chen, F; Chen, PM; Gonen, M; Juthani, R; Ma, K; Madajewski, B; Rudin, CM; Turker, MZ; Wiesner, U; Yoo, B; Zhang, L1

Reviews

1 review(s) available for gefitinib and deferoxamine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

2 other study(ies) available for gefitinib and deferoxamine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Molecular Engineering of Ultrasmall Silica Nanoparticle-Drug Conjugates as Lung Cancer Therapeutics.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 10-15, Volume: 26, Issue:20

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Deferoxamine; Drug Delivery Systems; Gefitinib; Humans; Lung Neoplasms; Mice; Nanoparticles; Positron-Emission Tomography; Protein Kinase Inhibitors; Silicon Dioxide; Small Molecule Libraries

2020